Litigation Details for Pacira Pharmaceuticals, Inc. v. Research Development Foundation (D. Nev. 2021)
✉ Email this page to a colleague
Pacira Pharmaceuticals, Inc. v. Research Development Foundation (D. Nev. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-12-23 |
| Court | District Court, D. Nevada | Date Terminated | |
| Cause | 28:2201 Declaratory Judgment | Assigned To | Richard Franklin Boulware II |
| Jury Demand | Both | Referred To | Daniel J. Albregts |
| Patents | 9,585,838 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pacira Pharmaceuticals, Inc. v. Research Development Foundation
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Pacira Pharmaceuticals, Inc. v. Research Development Foundation (D. Nev. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-08-08 | 152 | Order AND Order on Motion for Judgment AND Order on Motion for Summary Judgment AND Order on Motion for Summary Judgment | Office issued Patent No. 12 9,585,838 on March 7, 2017, which described this MVL production. ECF No. 18-4…last-to-expire patents. Id. 20 21 utilized patent, and one living, unutilized patent application” and…’495 patent is related to the same field of technology as the ’572 21 patent and the ’838 patent. ECF … The ’495 patent is not necessarily related to the ’572 patent. The ’495 patent’s disclosure 5 …whether the patent that Pacira uses to 4 manufacture 200L EXPAREL is “related to” the patent RDF previously | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
